Publication of new microbiological data for XF-73
Shares Magazine,
Destiny Pharma plc ("Destiny Pharma" or "the Company") New publication shows XF-73 drug potent against 2,527 Staphylococcus…
Destiny Pharma plc ("Destiny Pharma" or "the Company") New publication shows XF-73 drug potent against 2,527 Staphylococcus…
Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains Brighton…